![]() Quanterix Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches. | ![]() Olink Olink Proteomics is a company providing products and services for human protein biomarker discovery. | ![]() SomaLogic SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics. | IMIDomics IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients. | |
Founding Date | Founding Date 2007 | Founding Date 2004 | Founding Date 2000 | Founding Date 2015 |
Type | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | ||||
Locations | Locations Billerica, US HQ Baltimore, US Philadelphia, US San Diego, US San Francisco, US Seattle, US | Locations Uppsala, SE HQ Barcelona, ES Uppsala, SE Watertown, US | Locations Boulder, US HQ | Locations HQ |
Employees | Employees 24840% increase | Employees 582 | Employees 483 | Employees 3 |
Valuation ($) | Valuation ($) 506.2 m | Valuation ($) N/A | Valuation ($) 396.2 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $138.9m (FY, 2025) | Revenue (est.) $169.6m (FY, 2023) | Revenue (est.) $97.7m (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods $73.9m (FY, 2025) | Cost of goods $51.9m (FY, 2023) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $65m (FY, 2025) | Gross profit $119.9m (FY, 2023) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($107.2m) (FY, 2025) | Net income ($31.6m) (FY, 2023) | Net income ($109.2m) (FY, 2022) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 96.5m | Total funding raised N/A | Total funding raised $ 622.5m | Total funding raised $ 16.5m |

Olink Proteomics is a company providing products and services for human protein biomarker discovery.
View company
SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics.
View companyIMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients.
View company